Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Analysts at Ventum Cap Mkts dropped their FY2024 earnings per share (EPS) estimates for Jushi in a research note issued to investors on Monday, November 11th. Ventum Cap Mkts analyst A. Semple now expects that the company will earn ($0.27) per share for the year, down from their prior forecast of ($0.22). Ventum Cap Mkts has a "Hold" rating on the stock. The consensus estimate for Jushi's current full-year earnings is ($0.19) per share. Ventum Cap Mkts also issued estimates for Jushi's Q4 2024 earnings at ($0.05) EPS, FY2025 earnings at ($0.19) EPS and FY2026 earnings at ($0.17) EPS.
Jushi Stock Performance
JUSHF traded up $0.06 during trading on Thursday, hitting $0.41. 384,981 shares of the stock were exchanged, compared to its average volume of 264,607. The firm has a 50 day simple moving average of $0.50 and a 200 day simple moving average of $0.56. Jushi has a 1 year low of $0.22 and a 1 year high of $1.09. The firm has a market cap of $80.01 million, a price-to-earnings ratio of -1.51 and a beta of -0.86.
Jushi (OTCMKTS:JUSHF - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.04). Jushi had a negative net margin of 20.93% and a negative return on equity of 5,529.11%. The company had revenue of $61.61 million during the quarter, compared to the consensus estimate of $65.53 million.
Jushi Company Profile
(
Get Free Report)
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
See Also
Before you consider Jushi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.
While Jushi currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
